Observational studyInternational journal of clinical oncology2026

Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.

Ryosuke Kawagoe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.